Comparison of pre‐cryopreserved and post‐thaw‐and‐wash‐nucleated cell count on major outcomes following unrelated cord blood transplant in children
- 26 April 2012
- journal article
- clinical trial
- Published by Wiley in Pediatric Transplantation
- Vol. 16 (5), 438-442
- https://doi.org/10.1111/j.1399-3046.2012.01698.x
Abstract
McManus MP, Wang L, Calder C, Manes B, Evans M, Bruce K, Ho RH, Domm J, Frangoul H. Comparison of pre‐cryopreserved and post‐thaw‐and‐wash‐nucleated cell count on major outcomes following unrelated cord blood transplant in children. Engraftment and OS after umbilical CBT is highly dependent on the TNC. The contribution of the wash step to cell loss and ultimately the dose of cells available for transplant is not well described. To investigate the amount of cell loss after washing and its impact on major outcomes compared to pre‐cryopreserved TNC, we analyzed data from patients prospectively enrolled on a National Heart, Lung and Blood Institute sponsored cord blood transplant study between 1999 and 2003. There were 310 patients ≤18 yr of age with malignant (N = 218) or non‐malignant (N = 92) disease enrolled on this trial. Only single CBU were used. All CBU were thawed and washed using an identical process. The median TNC after thawing and washing (PTW) was 5.43 × 107/kg (79% recovery of cells). The cumulative incidence of neutrophil engraftment was significantly higher in patients receiving a PTW TNC ≥2.5 × 107/kg (p = 0.01). The cumulative incidence of TRM was higher among patients receiving post‐thaw‐and‐wash TNC 7/kg (p = 0.039). In conclusion, receiving a PTW TNC of 7/kg resulted in worse neutrophil engraftment and increased transplant‐related mortality compared to a PTW TNC of ≥2.5 × 107/kg.Keywords
This publication has 13 references indexed in Scilit:
- Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignanciesBlood, 2010
- Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignanciesBlood, 2008
- Assessment of cord blood hematopoietic cell parameters before and after cryopreservationTransfusion, 2007
- Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison studyThe Lancet, 2007
- Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banksTransfusion, 2006
- Results of the Cord Blood Transplantation Study (COBLT): Outcomes of Unrelated Donor Umbilical Cord Blood Transplantation in Pediatric Patients with Lysosomal and Peroxisomal Storage DiseasesTransplantation and Cellular Therapy, 2006
- Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samplesTransfusion, 2005
- Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: a grading algorithm versus blinded expert panel reviewTransplantation and Cellular Therapy, 2003
- Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survivalBlood, 2002
- Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution.Proceedings of the National Academy of Sciences of the United States of America, 1995